Diallo Jean-Simon, Péant Benjamin, Lessard Laurent, Delvoye Nathalie, Le Page Cécile, Mes-Masson Anne-Marie, Saad Fred
Centre de recherche du Centre hospitalier de l'Université de Montréal (CR-CHUM) and Institut du cancer de Montréal, Montreal, Quebec, Canada.
Prostate. 2006 Sep 1;66(12):1245-56. doi: 10.1002/pros.20455.
Inositol hexakisphosphate (IP6) is a phytochemical exhibiting anticancer activity. Because few prostate cancer (PCa) cell lines have been used to study IP6, we assessed its efficacy in a panel of PCa cell lines.
Using WST-1 assays we observed that, although androgens did not modulate its efficacy, IP6 was more active in androgen receptor (AR) negative cells than in AR-positive cells. Stable expression of the AR in PC3 cells (PC3(AR)) decreased the response to IP6, which was reversed by an AR-targeting siRNA. Furthermore, AR expression in PC3 cells resulted in significantly reduced caspase-3 activation (P < 0.001) and DNA fragmentation (P < 0.05) in response to IP6. Similarly, although treatment with IP6 caused the upregulation of NF-kappaB-responsive (IkappaB-alpha, IRF-2) and p53/E2F-responsive genes (Puma, Noxa) in PC3 cells, this increase was reduced in PC3AR cells (P < 0.01).
We conclude that resistance to IP6 can be linked to a ligand-independent AR function.
肌醇六磷酸(IP6)是一种具有抗癌活性的植物化学物质。由于很少有前列腺癌细胞系用于研究IP6,我们评估了其在一组前列腺癌细胞系中的疗效。
使用WST-1检测,我们观察到,虽然雄激素不调节其疗效,但IP6在雄激素受体(AR)阴性细胞中比在AR阳性细胞中更具活性。在PC3细胞(PC3(AR))中稳定表达AR可降低对IP6的反应,而靶向AR的siRNA可逆转这种反应。此外,PC3细胞中的AR表达导致对IP6反应时caspase-3激活(P < 0.001)和DNA片段化(P < 0.05)显著降低。同样,虽然用IP6处理导致PC3细胞中NF-κB反应性(IκB-α、IRF-2)和p53/E2F反应性基因(Puma、Noxa)上调,但在PC3AR细胞中这种增加减少(P < 0.01)。
我们得出结论,对IP6的抗性可能与配体非依赖性AR功能有关。